5.10Open5.10Pre Close0 Volume37 Open Interest15.00Strike Price0.00Turnover92.59%IV13.62%PremiumSep 20, 2024Expiry Date2.69Intrinsic Value100Multiplier5DDays to Expiry2.41Extrinsic Value100Contract SizeAmericanOptions Type0.9421Delta0.0600Gamma6.43Leverage Ratio-0.0223Theta0.0019Rho6.06Eff Leverage0.0024Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet